四级转诊中心神经外科手术静脉血栓栓塞预防的风险-获益比
该前瞻性评估在11436例神经外科手术患者中实施静脉血栓栓塞预防方案,术后皮下肝素5000国际单位每8小时一次,脊柱手术于术后第1天开始,颅脑手术于术后第2天开始,硬膜下、脑内及硬膜外血肿病例至术后第4天开始。共记录70例静脉血栓栓塞(总体0.6%),54例出血并发症,28例需手术干预,1例死亡。作者认为该方案在多种神经外科手术中具有良好风险-获益比。
要点
- 总体静脉血栓栓塞发生率为0.6%(70/11436),其中深静脉血栓28例、肺栓塞42例。
- 静脉血栓栓塞率最高的手术类型为畸形矫正(6.7%)、开放脑血管(6.5%)、硬膜下/脑内/硬膜外血肿(3.2%)、脊柱创伤(2.4%)及肿瘤开颅(1.6%)。
- 54例出血并发症发生于术后第2天或之后启动预防后,28例需手术干预,1例死亡。
核心结论
- 作者认为该静脉血栓栓塞预防方案在多种神经外科手术中提供了良好的风险-获益比。
研究设计与样本
- 前瞻性评估在11436例接受神经外科手术的患者中实施静脉血栓栓塞预防方案,为期24个月。
- 除非存在出血并发症,否则术后皮下肝素5000国际单位每8小时一次,脊柱手术于术后第1天开始,颅脑手术于术后第2天开始,硬膜下、脑内及硬膜外血肿病例至术后第4天开始。
主要发现
- 共记录70例静脉血栓栓塞(总体0.6%),包括28例深静脉血栓和42例肺栓塞。
- 静脉血栓栓塞率最高的手术类型为畸形矫正(6.7%)、开放脑血管(6.5%)、硬膜下/脑内/硬膜外血肿(3.2%)、脊柱创伤(2.4%)及肿瘤开颅(1.6%)。
- 70例静脉血栓栓塞中66例发生于药物预防期间,7例深静脉血栓进展为肺栓塞。
- 54例出血并发症发生于术后第2天或之后启动预防后,其中28例需手术干预,1例死亡;45例在初始出血事件发生时正在接受抗凝治疗。
- 估计延迟性出血并发症发生率为0.5%,研究队列中99.4%的患者未发生静脉血栓栓塞。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Pharmacological prophylaxis for venous thromboembolism (VTE) in the neurosurgical population is still a matter of debate, as the risk-to-benefit ratio is not well defined. OBJECTIVE: To further evaluate the risk-to-benefit ratio of VTE prophylaxis (VTEP) for all neurosurgical procedures. METHODS: A prospective evaluation was performed after the initiation of a VTEP protocol for 11 436 patients undergoing neurosurgical procedures over 24 mo. Unless a bleeding complication was present, 5000 international units of subcutaneous heparin every 8 h was ordered on postoperative day (POD) 1 for spine, POD2 for cranial, and by POD4 for subdural, intracerebral, and epidural hematoma cases. Incidence of VTE and any subsequent bleeding complications were noted. RESULTS: A total of 70 VTEs (0.6% overall) were documented (28 deep vein thrombosis, 42 pulmonary embnolism). The highest rates of VTE were associated with deformity (6.7%); open cerebrovascular (6.5%); subdural, intracerebral, and epidural hematoma (3.2%); spinal trauma (2.4%); and craniotomy for tumor (1.6%) cases. Seven cases of deep vein thrombosis progressed to pulmonary embolisms, and 66 of 70 VTEs occurred while on pharmacological VTEP. Fifty-four bleeding complications occurred on or after POD2 following initiation of VTEP. These bleeding complications consisted of any new clinically or radiographically observed hemorrhages. Twenty-eight of the 54 delayed bleeding complications required operative intervention with 1 mortality. Forty-five patients were on anticoagulation when the initial bleeding event occurred. Overall, an estimated 0.5% incidence of delayed bleeding complications was noted with 99.4% of patients within the study cohort remaining VTE free. CONCLUSION: This VTEP protocol was determined to afford a good risk-to-benefit ratio for a wide variety of neurosurgical procedures.
引用
- Agarwal N, Zenonos GA, Agarwal P, et al. Risk-to-Benefit Ratio of Venous Thromboembolism Prophylaxis for Neurosurgical Procedures at a Quaternary Referral Center. Neurosurgery. 2019. PMID: 29538700. doi:10.1093/neuros/nyy035
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。